Dr. Amy Archer is a Chicago, Illinois based female rheumatologist who is specialized in Rheumatology. Active license number of Dr. Amy Archer for Rheumatology is 036.130102 in Illinois. Dr. Amy Archer treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. Amy Archer speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
MD
Gender:
Female
Practice Address:
675 N Saint Clair St, Suite 14-100 (div Of Rheumatology), Chicago, Illinois, 60611-5975
Phone:
312-695-8628
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1528296431
NPI Enumeration Date:
30 Jun, 2009
NPI Last Update On:
27 Jul, 2012
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Amy Archer are as mentioned below.
License Number
Specialization
State
Status
036.130102
Rheumatologist
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
675 N Saint Clair St, Suite 14-100 (div Of Rheumatology) Chicago, Illinois
Zip:
60611-5975
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Amy Archer at 675 N Saint Clair St, Suite 14-100 (div Of Rheumatology), Chicago, Illinois or can call to book an appointment on 312-695-8628. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.